Categories Earnings, LATEST, Other Industries

Norfolk Southern (NYSE: NSC): Q4 2019 Earnings Snapshot

— Norfolk Southern Corporation (NYSE: NSC) reported its fourth-quarter 2019 earnings of $2.55 per share versus $2.28 per share expected.

— Railway operating revenue declined by 7% to $2.7 billion versus $2.7 billion expected. The decline was primarily due to a 9% drop in total volume.

— Railway operating expenses decreased by $90 million as lower compensation and benefits, fuel costs, equipment rents, and materials usage were partially offset by lower gains on operating property sales and increased purchased services expense.

— During the year 2019, the company experienced macroeconomic headwinds but results remained strong as the team expeditiously implemented productivity initiatives throughout the year.

— Looking ahead into the full year 2020, the company expects a flat revenue as the persistent headwinds in the Coal segment will offset the improved comparisons in Merchandise and Intermodal as the year progresses.

— The operating ratio is predicted to be greater than 235 basis points improvement in 2020 and is committed to 60% by 2021.

— Capital expenditures are anticipated to be 16-18% of revenue in 2020.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

PM Earnings: Key quarterly highlights from Philip Morris Q3 financial results

Philip Morris International Inc. (NYSE: PM) reported Third-quarter 2021 earnings results today. Net revenues increased 9% year-over-year to $8.1 billion. The reported net income amounted to $2.42 billion compared to

Halliburton stock slips on weaker-than-expected Q3 results

Halliburton (NYSE: HAL) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The company reported Q3 revenue of $3.9 billion, up 30% year-over-year and lower than the

Johnson & Johnson (JNJ) reports Q3 2021 earnings

Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue of $23.3 billion, up 10.7% year-over-year, with operational

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top